A randomized controlled double-blind study of rotigotine on neuropsychiatric symptoms in de novo PD
A randomized controlled double-blind study of rotigotine on neuropsychiatric symptoms in de novo PD
About this item
Full title
Author / Creator
Castrioto, A. , Thobois, S. , Anheim, M. , Quesada, J. L. , Lhommée, E. , Klinger, H. , Bichon, A. , Schmitt, E. , Durif, F. , Azulay, J. P. , Houeto, J. L. , Longato, N. , Philipps, C. , Pelissier, P. , Broussolle, E. , Moro, E. , Tranchant, C. , Fraix, V. , Krack, P. , for the Honeymoon study group and Honeymoon study group
Publisher
London: Nature Publishing Group UK
Journal title
Language
English
Formats
Publication information
Publisher
London: Nature Publishing Group UK
Subjects
More information
Scope and Contents
Contents
Management of apathy, depression and anxiety in Parkinson’s disease (PD) represents a challenge. Dopamine agonists have been suggested to be effective. This multicenter, randomized (1:1), double-blind study assessed the 6-month effect of rotigotine versus placebo on apathy, depression and anxiety in de novo PD. The primary outcome was the change of...
Alternative Titles
Full title
A randomized controlled double-blind study of rotigotine on neuropsychiatric symptoms in de novo PD
Authors, Artists and Contributors
Author / Creator
Identifiers
Primary Identifiers
Record Identifier
TN_cdi_doaj_primary_oai_doaj_org_article_34b6579169b943c7944a08d2e7aba062
Permalink
https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_doaj_primary_oai_doaj_org_article_34b6579169b943c7944a08d2e7aba062
Other Identifiers
ISSN
2373-8057
E-ISSN
2373-8057
DOI
10.1038/s41531-020-00142-x
